Breaking AI & Tech News Analyzed

Rockstar Games, the renowned studio behind the Grand Theft Auto series, has fallen victim to a cyberattack by the hacker group ShinyHunters. The group is demanding a ransom in exchange for not releasing stolen company data, including potentially sensitive information about the highly anticipated Grand Theft Auto VI.The attack, which was first reported on April 13, 2026, involves ShinyHunters threatening to leak data stolen from Rockstar Games' servers operated by a third-party vendor. The group initially set a deadline of April 14, 2026, for the company to enter negotiations.In a chilling message, ShinyHunters warned Rockstar: “Rockstar Games. Your … data was compromised … Pay or leak.” The group has a history of targeting major companies, including Microsoft, Cisco, and Ticketmaster.Rockstar Games has downplayed the impact of the hack, stating that only a “limited amount of non-material company information” was accessed and that there was no impact on players. However, given the high stakes surrounding Grand Theft Auto VI, which has been in development for nearly a decade and is expected to be one of the biggest releases in gaming history, any breach is a serious concern.The ShinyHunters group is linked to The Com, a loose network of cybercriminals, primarily English-speaking individuals aged 16 to 25. This group has been involved in previous high-profile hacks, including the Pornhub breach last year.This incident follows a previous major breach in 2022 when a teenager from the Lapsus$ hacking collective leaked 90 minutes of Grand Theft Auto VI gameplay footage. The hacker, Arion Kurtaj, was sentenced to an indefinite hospital order in 2023. Rockstar reportedly spent $5 million and thousands of hours recovering from that incident.The development costs for Grand Theft Auto VI are estimated to be close to $2 billion, and the game’s tight secrecy makes any data breach particularly damaging. Originally slated for Autumn 2025, the game has been delayed to November 19, 2026.

For the first time, thousands of cancer patients from Black and minority ethnic backgrounds will benefit from an enhanced genetic test offered by the NHS. The new screening expands the panel of DPYD gene variants from four to five, directly addressing a long‑standing bias that left non‑white patients vulnerable to dangerous chemotherapy side‑effects. In England, patients slated for chemotherapy undergo a genetic check that can guide dose adjustments and mitigate adverse reactions such as mouth sores, hair loss, nausea, fatigue, and, in severe cases, death. Up to 40% of the 38,000 individuals receiving fluoropyrimidine‑based chemotherapy each year experience a harmful drug reaction. Previously, the test only targeted four DPYD variants common in people of European descent, meaning many Black patients received inaccurate “all‑clear” results. The addition of a fifth variant—more prevalent among African, Caribbean and other minority groups—means clinicians can now identify patients at risk who were previously missed. Since its rollout at Manchester University NHS Foundation Trust last September, three minority‑ethnic patients have had their initial chemotherapy doses adjusted, lowering their chance of a potentially fatal reaction. Dr Veline L’Esperance, senior clinical adviser at the NHS Race and Health Observatory, called the change “tangible results for patients who have historically been left behind.” She emphasized that the update shifts the discussion on ethnic health inequality from rhetoric to actionable care. Prof Habib Naqvi, chief executive of the NHS Race and Health Observatory, described the development as a “groundbreaking outcome” for chemotherapy safety, while noting that ethnic minorities remain under‑represented in genomic research and biobanks. He warned that broader inclusion is essential for the promised benefits of precision medicine to reach all communities. Prof Dame Sue Hill, chief scientific officer for NHS England, highlighted the significance of discovering the fifth variant: “Personalising chemotherapy based on genetics can save lives and reduce harmful side‑effects, especially for patients of African ancestry.” She added that the North West NHS Genomic Medicine Service has already demonstrated the practical impact of this approach. These steps come amid broader evidence that minority patients in the UK face longer diagnostic waits, more GP visits before a cancer diagnosis, and lower perceived support during treatment. The expanded DPYD test represents a concrete effort to close those gaps and ensure equitable, science‑driven care for all cancer patients.

Conversations about mundane topics are often dreaded, but research suggests that people enjoy them more than they anticipate. A study involving 1,800 volunteers found that participants enjoyed chatting about dull subjects, such as the stock market or vegan diets, more than they expected. The findings indicate that by avoiding potentially dull exchanges, individuals may miss out on the mood boost and health benefits that come with connecting with others. Elizabeth Trinh, a PhD candidate in management and organisations at the University of Michigan, noted that people tend to underestimate how interesting and enjoyable conversations about boring topics can be. Trinh and her colleagues conducted a series of experiments to gauge how people responded to conversations on dull topics. Participants were asked to predict how much they would enjoy discussing topics they considered boring, and then engage in brief conversations about those topics. The results, published in the Journal of Personality and Social Psychology, showed that people consistently found the conversations more enjoyable than they expected. The surprise enjoyment arises because individuals base their expectations on static components, such as the topic and the other person, rather than dynamic components, like the conversation itself. Trinh suggests that people may benefit from lowering the bar for what makes a conversation worth having and reframing conversational goals. Instead of focusing on enjoyment, individuals could think about what they might learn from the conversation. Nicholas Epley, a professor of behavioural science at the University of Chicago, added that the fear of a boring conversation shouldn’t prevent people from starting one. “If a conversation is boring once you’re in it, you also have a surprising amount of power to make it better!”

Recent CDC data reveal a dramatic 1,200% increase in kratom‑related poisonings across the United States over the last ten years, with the most pronounced surge recorded in 2025. Researchers link this rise to the growing presence of 7‑hydroxymitragynine (7‑OH), a synthetically produced compound that mimics kratom’s effects but carries opioid‑like risks. Walter Prozialeck, pharmacology professor at Midwestern University, said the trend was expected, noting that the synthetic alkaloid has entered the market through energy drinks and other products since 2024. Christopher McCurdy of the University of Florida warned that marketing 7‑OH as “enhanced kratom” blurs the line for consumers, turning poison‑control calls into a conflated metric for both natural and synthetic products. By contrast, natural kratom (Mitragyna speciosa)—a Southeast Asian plant used for centuries as a pain reliever—has demonstrated a relatively favorable safety profile in animal and human studies. A 2018 statement from then‑HHS Secretary Brett Giroir rejected the DEA’s push to schedule kratom as a Schedule I substance, citing insufficient evidence of harm. Despite the scientific distinction, several states have moved to implement or propose blanket bans on all kratom products, prompting concern from clinicians and patient advocates. A recent user survey indicated that about 50% of respondents rely on kratom for chronic pain, while roughly 40% use it during addiction recovery. Personal testimonies underscore the plant’s therapeutic role. Jeff Maslan, a 68‑year‑old Californian with severe osteoarthritis, credits kratom with easing opioid withdrawal after multiple surgeries. Similarly, “Steven,” a disabled California resident, describes how kratom eliminated unbearable oxycodone withdrawal symptoms without producing the euphoric “warm fuzzy” feeling typical of opioids. Researchers emphasize that 7‑OH carries genuine opioid hazards, including addiction, severe withdrawal, and respiratory depression that can lead to fatal overdose. In animal models, 7‑OH demonstrated the same respiratory‑depression risk as classic opioids, whereas kratom’s primary alkaloid did not. Prozialeck and colleagues explain that kratom’s pharmacology is more nuanced: it partially activates opioid receptors while also engaging adrenergic and serotonin pathways, resembling a hybrid of a weak opioid and an SNRI‑type antidepressant. This multimodal action likely accounts for its lower euphoric potential and the reported boost in energy among users. Nevertheless, experts caution that kratom is not without risk. Fatal poisonings often involve co‑ingestion of potent opioids such as fentanyl, suggesting that some users may cycle between kratom and stronger substances, raising overdose danger due to reduced opioid tolerance. Additionally, heavy‑metal contamination has been detected in certain kratom batches, though the source—soil, processing, or storage—remains unclear. Given these complexities, the consensus among scholars like Austin Zamarripa (Johns Hopkins) is that natural kratom should remain accessible, while concentrated 7‑OH products merit stricter regulation. “These products may offer meaningful benefits to some individuals, and those benefits could be lost if access is restricted too broadly,” Zamarripa said, urging a differentiated policy approach. As the debate unfolds, patients like Steven worry that a sweeping ban would ignore the nuanced safety profile of the plant. “There’s corn on the cob, there’s high‑fructose corn syrup, there’s whiskey— all derived from corn but fundamentally different,” he remarked, highlighting the need for targeted, evidence‑based regulation rather than a one‑size‑fits‑all prohibition.

President Donald Trump's 2027 budget proposal has drawn sharp criticism for its stark prioritization of military spending over healthcare and social welfare programs, despite the US facing a crisis of deaths from avoidable causes. The budget proposes a $1.5 trillion military expenditure, a significant increase from previous years, while cutting the Department of Health and Human Services (HHS) budget by 12%.The US faces a grim reality in healthcare, with deaths from treatable conditions nearly twice the rate of countries like Spain, France, Japan, and Australia. Many Americans struggle to access healthcare due to cost, with the US having the highest out-of-pocket expenses for medical services among its peers. The proposed budget cuts to HHS and other non-defense programs will likely exacerbate these issues.Trump's budget plan also slashes funding for programs like Medicaid and the Affordable Care Act, potentially leaving 15 million Americans without health insurance, according to analysts. The administration's justification for these cuts includes claims of corruption and wasteful spending in certain programs.The budget proposal has been seen as a betrayal by many Americans who supported Trump based on his promises to help working-class individuals. The data suggests that if Trump continues to ignore the needs of his base, he may soon lose their support. American men and women are dying, and these individuals are also Trump's voters.The Pentagon's recent spending on conflicts, such as the war against Iran, has been substantial, with estimates suggesting $12.7 billion in the first six days and $28 billion in just over five weeks. The budget proposal's focus on military spending raises concerns about the impact on the US economy and society.

Malina Lee, a 31‑year‑old wedding baker from San Antonio, joined TikTok in 2020 to pass the lockdown‑induced boredom and promote her business. Four years later, an anonymous commenter called “PickleFart” noticed an asymmetrical neck in one of her videos and suggested she check for a goiter.The tip proved accurate: doctors confirmed thyroid cancer. Lee received prompt treatment and, within a year, was declared cancer‑free. She told the outlet that her oncologist was amazed at how early the disease was caught, crediting the TikTok comment as the catalyst.Lee’s experience is part of a growing trend where TikTok’s hyper‑targeted algorithm surfaces health‑related content that resonates with users’ unnoticed symptoms. In several cases, community members have flagged potential conditions that clinicians initially missed.The “PickleFart” persona belongs to Billie Jean Tuomi, who calls herself the “thyroid avenger.” A thyroid‑cancer survivor herself (diagnosed in 2012), Tuomi now scans videos for neck asymmetry and gently advises creators to seek a thyroid panel—a blood test measuring hormone levels and antibodies. The American Thyroid Association recommends adults start routine thyroid testing at age 35, or annually for high‑risk individuals.Tuomi estimates she has flagged dozens of videos, with at least four confirmed serious thyroid issues, including Lee’s. She stresses she does not claim to diagnose, merely urges viewers to consult a physician. After a viral comment, she received a flood of private messages with neck photos, prompting her to change her username.Lee, inspired by Tuomi’s intervention, has begun commenting on other users’ videos, helping one individual discover an enlarged thyroid that required removal. She describes the process as a “domino effect” of community‑driven health awareness.Medical professionals acknowledge the double‑edged nature of this phenomenon. Craig Mittleman, director of emergency services at Lawrence + Memorial Hospital, notes a rise in patients arriving with self‑diagnoses sourced from social media. While this can empower patients to ask informed questions, it also burdens clinicians with debunking misinformation.Gender disparities amplify the issue: research shows women are more likely to seek health information online, often after feeling dismissed by traditional providers. TikTok user Tori Mosser, a 23‑year‑old filmmaker, credits a direct message suggesting chronic appendicitis for prompting surgery that resolved her chronic vomiting episodes.Both Lee and Mosser emphasize the therapeutic value of finding a supportive community on TikTok, especially for invisible or chronic illnesses that are frequently minimized in clinical settings.

In a significant display of public dissent, hundreds of people gathered in London's Trafalgar Square on Saturday to protest against the UK government's ban on the Palestine Action campaign group. The demonstration, organized by Defend Our Juries (DOJ), drew a large crowd holding signs that read, 'I oppose genocide. I support Palestine Action.'Police responded to the peaceful vigil by beginning arrests, with several individuals carried away from the scene. Notably, an elderly woman using walking sticks was escorted away by police, highlighting the strict measures taken by authorities.The protest was sparked by the UK government's decision to prospect Palestine Action as a terrorist organization in July 2025, making it illegal to be a member of or express support for the group. This move has been met with criticism, particularly after the High Court ruled in February that the government's proscription was unlawful and disproportionate, citing breaches of freedom of expression.Despite the court's ruling, the Metropolitan Police initially indicated they would not arrest individuals showing support for Palestine Action but reversed their policy on March 25. This U-turn has been criticized for undermining the court's decision and restricting free speech.Protesters, including Qesser Zuhrah, a former hunger striker from the Palestine Action network, expressed their dissatisfaction with the police's actions. Zuhrah stated that the Met's decision to resume arrests shows that the police 'don't serve us' and only work to reinforce government interests.The UK government's appeal against the High Court ruling is set to be heard by the Court of Appeal on April 28 and 29. Organizers estimated that 1,500 people participated in the vigil, demonstrating significant public support for Palestine Action and concerns over the government's stance on free speech.

A violent incident unfolded at New York City's iconic Grand Central station on Saturday, when a man armed with a machete allegedly attacked and wounded three elderly individuals.Police responded swiftly to the situation, and one officer opened fire, striking the attacker. The man was taken to a local hospital in critical condition.The victims, identified as an 84-year-old man, a 70-year-old woman, and a 65-year-old man, were hospitalized in stable condition. The NYPD reported that the incident occurred at 9:40am Eastern Time (13:40 GMT).Grand Central station, a major transit hub in Midtown Manhattan, is renowned for its Beaux-Arts architecture and is one of the most visited tourist attractions globally, with an average of 750,000 travelers and visitors daily.

Match details: Chelsea host Manchester City at Stamford Bridge on Sunday, 12 April, 4:30 pm BST (15:30 GMT). Live coverage and pre‑match analysis will be available on Al Jazeera Sport from 12:30 GMT. City sit second in the Premier League, trailing league leaders Arsenal by nine points after Arsenal played one more game. A win at Chelsea could shrink the gap to six points, and a victory for Arsenal over Bournemouth on Saturday would widen the gap to twelve, putting immense pressure on Pep Guardiola’s side to collect maximum points. Chelsea, currently sixth, are desperate to reignite their push for a top‑five finish that guarantees Champions League football next season. They sit just one point behind Liverpool, who occupy the final European spot. Guardiola warns of zero‑margin for error Speaking on Friday, Pep Guardiola admitted City’s season has been “inconsistent” and stressed that the squad must win every remaining match to retain any chance of clinching the title. He highlighted the demanding run of fixtures ahead, beginning with the Chelsea trip and followed by a home clash with Arsenal on 19 April. “We need to win all of them; otherwise we won’t have a chance to fight until the end,” Guardiola said, acknowledging points dropped earlier in the campaign. Bernardo Silva’s future remains uncertain Midfielder Bernardo Silva, a six‑time Premier League champion with City, is in the final year of his contract. Guardiola expressed a personal desire to keep the Portuguese international at the club but admitted he does not know the player’s decision. “I’m a bit grumpy because I wasn’t informed of his plans,” the manager said, praising Silva’s competitiveness and importance in big‑match moments. Enzo Fernández excluded despite apology Chelsea boss Liam Rosenior confirmed that midfielder Enzo Fernández will remain on the bench for the Sunday fixture, even after the Argentine apologised for comments that questioned his future at Stamford Bridge. Rosenior emphasized the club’s collective values, stating, “Football is a team sport, not about individuals,” and hinted that Fernández could feature again after this match. Chelsea’s Champions League ambition Rosenior reiterated confidence in his squad’s ability to secure a top‑five finish, noting that despite a recent dip in form, the team has consistently created problems for opponents. Historical head‑to‑head The two clubs have met 181 times in competitive fixtures: Chelsea have won 71, City 68, with 42 draws. Notably, Chelsea have not beaten City since the 2021 Champions League final. Recent encounters (last 10): 04 Jan 2026 – Man City 1‑1 Chelsea (Premier League) 25 Jan 2025 – Man City 3‑1 Chelsea (Premier League) 18 Aug 2024 – Chelsea 0‑2 Man City (Premier League) 20 Apr 2024 – Man City 1‑0 Chelsea (FA Cup semi‑final) 17 Feb 2024 – Man City 1‑1 Chelsea (Premier League) 12 Nov 2023 – Chelsea 4‑4 Man City (Premier League) 21 May 2023 – Man City 1‑0 Chelsea (Premier League) 08 Jan 2023 – Man City 4‑0 Chelsea (FA Cup third round) 05 Jan 2023 – Chelsea 0‑1 Man City (Premier League) 09 Nov 2022 – Man City 2‑0 Chelsea (League Cup third round) Team news – Chelsea Rosenior confirmed centre‑back Levi Colwill has returned to training after a serious knee injury, though he remains a selection risk. Right‑back Reece James is training after a hamstring issue. Defender Trevoh Chalobah and winger Jamie Gittens are still sidelined. Predicted starting XI: Sanchez; Gusto, Fofana, Adarabioyo, Cucurella; Santos, Caicedo; Neto, Palmer, Estevao; Pedro. Team news – Manchester City Defender Rúben Dias continues to recover from a muscle problem and is unavailable. Josko Gvardiol remains out with a tibial fracture sustained in January. Predicted starting XI: Donnarumma; Nunes, Khusanov, Guehi, O’Reilly; Silva, Rodri; Semenyo, Cherki, Doku; Haaland. The outcome of this clash could dramatically reshape the Premier League title race and determine whether Chelsea can keep their Champions League aspirations alive.